TPSD1, tryptase delta 1, 23430

N. diseases: 27; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007222
Disease: Cardiovascular Diseases
Cardiovascular Diseases
0.010 Biomarker group BEFREE Mast cell tryptase - Marker and maker of cardiovascular diseases. 30877022 2019
CUI: C0010054
Disease: Coronary Arteriosclerosis
Coronary Arteriosclerosis
0.010 Biomarker disease BEFREE In this study, total IgE and mast cell tryptase were measured in a series of forensic autopsy cases including non-allergic cardiac deaths (14 cases with minimal or no coronary atherosclerosis, 14 cases with significant coronary artery atherosclerosis without acute coronary thrombosis, and 14 cases with significant coronary artery atherosclerosis and acute coronary thrombosis or myocardial infarction) and non-allergic non-cardiac deaths (21 cases with death due to hanging and 21 cases with death due to intracranial gunshot wounds), in order to correlate laboratory results with morphological findings and compare them to conclusions reported in the clinical setting. 30599216 2019
CUI: C0010072
Disease: Coronary Thrombosis
Coronary Thrombosis
0.010 Biomarker disease BEFREE In this study, total IgE and mast cell tryptase were measured in a series of forensic autopsy cases including non-allergic cardiac deaths (14 cases with minimal or no coronary atherosclerosis, 14 cases with significant coronary artery atherosclerosis without acute coronary thrombosis, and 14 cases with significant coronary artery atherosclerosis and acute coronary thrombosis or myocardial infarction) and non-allergic non-cardiac deaths (21 cases with death due to hanging and 21 cases with death due to intracranial gunshot wounds), in order to correlate laboratory results with morphological findings and compare them to conclusions reported in the clinical setting. 30599216 2019
CUI: C0282488
Disease: Interstitial Cystitis
Interstitial Cystitis
0.010 AlteredExpression disease BEFREE The expression of tissue necrotic factor-α, vascular endothelial growth factor, CD31, transforming growth factor-β and SLUG was significantly increased in non-Hunner type interstitial cystitis and Hunner type interstitial cystitis patients compared with controls whereas the significant increases in the expression of mast cell tryptase and collagen were observed in Hunner type interstitial cystitis patients compared with controls and non-Hunner type interstitial cystitis patients. 31144750 2019
CUI: C0600040
Disease: Chronic interstitial cystitis
Chronic interstitial cystitis
0.010 AlteredExpression disease BEFREE The expression of tissue necrotic factor-α, vascular endothelial growth factor, CD31, transforming growth factor-β and SLUG was significantly increased in non-Hunner type interstitial cystitis and Hunner type interstitial cystitis patients compared with controls whereas the significant increases in the expression of mast cell tryptase and collagen were observed in Hunner type interstitial cystitis patients compared with controls and non-Hunner type interstitial cystitis patients. 31144750 2019
CUI: C0036221
Disease: Mast-Cell Sarcoma
Mast-Cell Sarcoma
0.010 Biomarker disease BEFREE Histopathological, immunohistochemical, and flow cytometry studies of the resection specimens showed the tumor to be mostly composed of CD117-positive and mast cell tryptase-positive cells with features consistent with mast cell sarcoma. 28992848 2018
CUI: C0009918
Disease: Contracture of joint
Contracture of joint
0.010 Biomarker disease BEFREE Serum Mast Cell Tryptase as a Marker of Posttraumatic Joint Contracture in a Rabbit Model. 28212251 2017
CUI: C4020898
Disease: Overactive bladder syndrome
Overactive bladder syndrome
0.010 Biomarker disease BEFREE Bladder biopsies from patients with bladder pain syndrome/interstitial cystitis, including 12 with and 19 without Hunner lesions, 13 with overactive bladder syndrome and 12 healthy controls, were analyzed by immunohistochemistry with antibodies to the nerve cell marker PGP9.5 (neuron-specific protein gene product 9.5), p75<sup>NTR</sup> (p75 neurotrophin receptor), the B-lymphocyte marker CD20 and mast cell tryptase. 27378135 2017
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.010 Biomarker disease BEFREE However, the role of mast cell tryptase (MCT) in human pancreatic cancer angiogenesis is still not well documented. 27240355 2016
CUI: C0346647
Disease: Malignant neoplasm of pancreas
Malignant neoplasm of pancreas
0.010 Biomarker disease BEFREE However, the role of mast cell tryptase (MCT) in human pancreatic cancer angiogenesis is still not well documented. 27240355 2016
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.010 Biomarker disease BEFREE This study examined expression of PAR2 and endogenous proteinase activators (trypsin-2, mast cell tryptase) and proteinase inhibitors (serpin-A5, serpin-A13) in areas vulnerable and resistant to neurodegeneration in Parkinson's disease at different Braak α-synuclein stages of the disease in post-mortem brain. 25982926 2015
CUI: C0029172
Disease: Oral Submucous Fibrosis
Oral Submucous Fibrosis
0.010 AlteredExpression disease BEFREE Altered immunohistochemical expression of mast cell tryptase and chymase in the pathogenesis of oral submucous fibrosis and malignant transformation of the overlying epithelium. 24874976 2014
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE Serine proteases such as trypsin and mast cell tryptase cleave protease-activated receptor-2 (PAR2) at R(36)↓S(37) and reveal a tethered ligand that excites nociceptors, causing neurogenic inflammation and pain. 25118282 2014
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.010 AlteredExpression phenotype BEFREE Altered immunohistochemical expression of mast cell tryptase and chymase in the pathogenesis of oral submucous fibrosis and malignant transformation of the overlying epithelium. 24874976 2014
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
0.010 Biomarker disease BEFREE We conclude that: 1) Hp infection is associated with a decreased risk for food allergy; 2) presence of Hp in food allergy patients has ameliorating effect on the production of allergy mediators such as ECP and mast cell tryptase and 3) Hp infection appears to be a protective factor against food allergy. 18758415 2008
CUI: C4554344
Disease: IgE-mediated food allergy
IgE-mediated food allergy
0.010 Biomarker disease BEFREE We conclude that: 1) Hp infection is associated with a decreased risk for food allergy; 2) presence of Hp in food allergy patients has ameliorating effect on the production of allergy mediators such as ECP and mast cell tryptase and 3) Hp infection appears to be a protective factor against food allergy. 18758415 2008
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.010 Biomarker phenotype BEFREE Inflammatory proteases (mast cell tryptase and trypsins) cleave protease-activated receptor 2 (PAR2) on spinal afferent neurons and cause persistent inflammation and hyperalgesia by unknown mechanisms. 15128844 2004
CUI: C0021390
Disease: Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
0.010 AlteredExpression group BEFREE PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease. 11804840 2002
CUI: C0023467
Disease: Leukemia, Myelocytic, Acute
Leukemia, Myelocytic, Acute
0.010 AlteredExpression disease BEFREE Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. 11568008 2001
CUI: C0235989
Disease: Renal interstitial fibrosis
Renal interstitial fibrosis
0.010 Biomarker disease BEFREE These findings suggest that mast cell tryptase plays a role in the proliferation and extracellular matrix protein production of renal interstitial fibroblasts and thus contributes to the development of renal interstitial fibrosis. 11461939 2001
CUI: C1969372
Disease: Tubulointerstitial fibrosis
Tubulointerstitial fibrosis
0.010 Biomarker phenotype BEFREE These findings suggest that mast cell tryptase plays a role in the proliferation and extracellular matrix protein production of renal interstitial fibroblasts and thus contributes to the development of renal interstitial fibrosis. 11461939 2001
CUI: C0687140
Disease: Hemangioma of skin
Hemangioma of skin
0.010 Biomarker disease BEFREE Using specific antibodies to mast cell tryptase, tissue macrophage, and bFGF, we demonstrate that cytoplasmic bFGF immunoreactivity is localized to 96.8 +/- 9.6% of tryptase-positive cells in human fibrotic lung tissue (n = 10), 82.3 +/- 6.9% of tryptase-positive cells in rheumatoid synovia (n = 6), and 93.1 +/- 4.8% of tryptase-positive cells in skin hemangioma (n = 5). 7545872 1995
CUI: C0004096
Disease: Asthma
Asthma
0.020 AlteredExpression disease BEFREE The percentage of macrophages correlated negatively with the expression of mast cell tryptase and ECP in COPD, and with CXCL8 in asthma. 27739024 2018
CUI: C0024899
Disease: Mastocytosis
Mastocytosis
0.020 GeneticVariation disease BEFREE Formalin-fixed specimens of 35 patients with vulvodynia were evaluated immunohistochemically with antibodies to CD 3,4,8,20,117c and human mast cell tryptase, and for WHO-criteria of neoplastic mastocytosis (>25% spindled mast cell, CD25 expression, point mutations of the c-kit gene (D816V), and chronically elevated serum tryptase levels). 25912132 2015
CUI: C0024899
Disease: Mastocytosis
Mastocytosis
0.020 Biomarker disease BEFREE Serum mast cell tryptase levels are used as a diagnostic criterion and surrogate marker of disease severity in mastocytosis. 17449330 2007